Omalizumab as Third-Line Therapy for Urticaria During Pregnancy

Fecha
2017
Autor
Ensina, L. F. [UNIFESP]
Cusato-Ensina, A. P.
Camelo-Nunes, I. C. [UNIFESP]
Sole, D. [UNIFESP]
Tipo
Editorial
ISSN
1018-9068
Es parte de
Journal Of Investigational Allergology And Clinical Immunology
DOI
10.18176/jiaci.0179
Metadatos
Mostrar el registro completo del ítem
Cita
Journal Of Investigational Allergology And Clinical Immunology. Barcelona, v. 27, n. 5, p. 326-327, 2017.
Palabras clave
Urticaria
Omalizumab
Angioedema
Therapeutics
URI
https://repositorio.unifesp.br/handle/11600/55425
Colecciones